ArticleFrontiers in public health2025
Unveiling the psychosocial and academic implications of living with sickle cell disease among undergraduates in a private university in Nigeria.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Temporal patterns of haemoglobin phenotypes among Nigerian university students based on ten years of surveillance data.Scientific reports · 2026Article
- CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program.Gates open research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sickle cell disease (SCD), a disease characterized with abnormal red blood cell morphology and is associated with diverse clinical manifestations and contribute to many psychosocial problems like social stigma, strained relationships and reduced self-esteem. SCD is highly prevalent in Sub-Saharan Africa, with Nigeria having the largest burden. This qualitative study is aimed at exploring possible psychosocial and academic challenges associated with sickle cell disease among undergraduates in Nigeria. Methods: From September 2023 to February 2024, the authors conducted an exploratory descriptive study using in-depth interviews among 22 undergraduate students with SCD at Bowen University, Osun State, Nigeria, employing an in-depth interviewer guide. Ethical approval was obtained from Bowen University Ethical Review Board prior to the conduct of the study. The data was analyzed using inductive thematic analysis. Results: Six (6) distinct themes emerged from the research data and each of the themes was linked to the study objectives. Many of the participants expressed disruption of academic activities by frequent SCD crisis. This negatively affected their academic performance, and sometimes led to feelings of frustration. Furthermore, the recurrent battles with pain due to vascular occlusion took a toll on their emotional and psychological health. They also experienced stigmatization and strained interpersonal relationships which negatively influenced their mental well-being. Conversely, some SCD patients enjoy some social support from colleagues and family members which gives hope and succor to them during difficult times. Conclusion: This study reveals that undergraduates with SCD face various academic and psychosocial challenges that affect their overall performance. The findings underscored the need for increased awareness, support, and understanding to better assist undergraduates with SCD in managing their health and academic responsibilities effectively. Considering the chronic nature of SCD and its myriads of psychosocial and academic challenges, measures should be put in place to mitigate the challenges and enable them to live a fulfilling life.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.